Description

Biobanking refers to the process by which samples of bodily fluid or tissue are collected for research use to improve our understanding of health and diseases. The global biobanking market is poised to grow by US$ 18.0 billion from 2022 to 2028, registering a CAGR of 4.5% during the forecast period, according to StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for biobanking. The global biobanking market is segmented on the basis of sample type, type, biobank format, ownership, application, and region. By sample type, the global biobanking market has been segmented into biofluids, DNA/RNA, stem cells, tissues, others. The biofluids segment was the largest contributor to the global biobanking market in 2021. Based upon type, the global biobanking market is categorized into partnership, standalone. According to the research, the standalone segment had the largest share in the global biobanking market. On the basis of biobank format, the global biobanking market has been segmented into diseased-oriented biobanks, population-based biobanks. The diseased-oriented biobanks segment held the largest revenue share in 2021. By ownership, the global biobanking market has been segmented into national & regional agencies, universities, non-profit organization, private organization. Globally, the national & regional agencies segment made up the largest share of the biobanking market. Based on application, the global biobanking market is categorized into research, therapeutics. In terms of geography, the global biobanking market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The global biobanking market is highly competitive. As of 2021, the major players in the global biobanking market were All of Us, Auria Biobank, Biobank Graz, BioBank Japan (BBJ), Biobank VAST, China Kadoorie Biobank (CKB), China National GeneBank DataBase (CNGB), Danish National Biobank, deCODE genetics Inc., EuroBioBank, Kaiser Permanente Research Bank, National Liver Disease Biobank, NIGMS Human Genetic Cell Repository, The Cancer Human Biobank (caHUB), THL Biobank/Finnish Institute for Health and Welfare (THL), UK Biobank Limited, Uppsala Biobank. Competitive landscape gives a description of the competitive nature of the global biobanking market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the biobanking market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


Report Scope

Sample type: biofluids, DNA/RNA, stem cells, tissues, others
Type: partnership, standalone
Biobank format: diseased-oriented biobanks, population-based biobanks
Ownership: national & regional agencies, universities, non-profit organization, private organization
Application: research, therapeutics
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: All of Us, Auria Biobank, Biobank Graz, BioBank Japan (BBJ), Biobank VAST, China Kadoorie Biobank (CKB), China National GeneBank DataBase (CNGB), Danish National Biobank, deCODE genetics Inc., EuroBioBank, Kaiser Permanente Research Bank, National Liver Disease Biobank, NIGMS Human Genetic Cell Repository, The Cancer Human Biobank (caHUB), THL Biobank/Finnish Institute for Health and Welfare (THL), UK Biobank Limited, Uppsala Biobank


Key Benefits for Stakeholders

– Get a comprehensive picture of the global biobanking market
– Identify regional strategies and strategic priorities on the basis of local data
– Pinpoint growth sectors and trends for investment


Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Biobanking market overview
Part 3. Market breakdown by sample type
– Biofluids
– DNA/RNA
– Stem cells
– Tissues
– Others
Part 4. Market breakdown by type
– Partnership
– Standalone
Part 5. Market breakdown by biobank format
– Diseased-oriented biobanks
– Population-based biobanks
Part 6. Market breakdown by ownership
– National & regional agencies
– Universities
– Non-profit organization
– Private organization
Part 7. Market breakdown by application
– Research
– Therapeutics
Part 8. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 9. Key companies
– All of Us
– Auria Biobank
– Biobank Graz
– BioBank Japan (BBJ)
– Biobank VAST
– China Kadoorie Biobank (CKB)
– China National GeneBank DataBase (CNGB)
– Danish National Biobank
– deCODE genetics, Inc.
– EuroBioBank
– Kaiser Permanente Research Bank
– National Liver Disease Biobank
– NIGMS Human Genetic Cell Repository
– The Cancer Human Biobank (caHUB)
– THL Biobank/Finnish Institute for Health and Welfare (THL)
– UK Biobank Limited
– Uppsala Biobank
About StrategyHelix
Disclaimer


USD 650

Product Type

Industry Statistics

Release Date

November 2022

Region

Global

Pages

18

REQUEST SAMPLE

Global Biobanking Market 2022

Please fill out our form and we will get back to you.

CUSTOM RESEARCH

Global Biobanking Market 2022

Please fill out our form and we will get back to you.

login